Vertex Pharmaceuticals Incorporated (VRTX)
USD 451.61
(-4.85%)
USD 451.61
(-4.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.6 Billion USD | 9.25% |
| 2022 | 7.85 Billion USD | 17.69% |
| 2021 | 6.67 Billion USD | 21.96% |
| 2020 | 5.46 Billion USD | 51.29% |
| 2019 | 3.61 Billion USD | 37.04% |
| 2018 | 2.63 Billion USD | 19.18% |
| 2017 | 2.21 Billion USD | 48.39% |
| 2016 | 1.49 Billion USD | 64.5% |
| 2015 | 906.79 Million USD | 74.58% |
| 2014 | 519.42 Million USD | -51.98% |
| 2013 | 1.08 Billion USD | -13.27% |
| 2012 | 1.24 Billion USD | -6.24% |
| 2011 | 1.33 Billion USD | 918.16% |
| 2010 | 130.64 Million USD | 48.71% |
| 2009 | 87.84 Million USD | -45.03% |
| 2008 | 159.81 Million USD | -13.66% |
| 2007 | 185.1 Million USD | -9.34% |
| 2006 | 204.18 Million USD | 35.41% |
| 2005 | 150.79 Million USD | 55.35% |
| 2004 | 97.06 Million USD | 47.04% |
| 2003 | 66.01 Million USD | -50.29% |
| 2002 | 132.8 Million USD | 3.87% |
| 2001 | 127.86 Million USD | 72.68% |
| 2000 | 74.04 Million USD | 13.92% |
| 1999 | 65 Million USD | 32.92% |
| 1998 | 48.9 Million USD | 3.16% |
| 1997 | 47.4 Million USD | 187.27% |
| 1996 | 16.5 Million USD | -36.05% |
| 1995 | 25.8 Million USD | 11.69% |
| 1994 | 23.1 Million USD | -27.36% |
| 1993 | 31.8 Million USD | 381.82% |
| 1992 | 6.6 Million USD | 32.0% |
| 1991 | 5 Million USD | 117.39% |
| 1990 | 2.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.34 Billion USD | 9.07% |
| 2024 Q3 | 2.37 Billion USD | 5.15% |
| 2024 Q2 | 2.26 Billion USD | -3.49% |
| 2023 FY | 8.57 Billion USD | 9.25% |
| 2023 Q1 | 2.1 Billion USD | 4.38% |
| 2023 Q2 | 2.18 Billion USD | 3.64% |
| 2023 Q4 | 2.14 Billion USD | -0.7% |
| 2023 Q3 | 2.16 Billion USD | -0.91% |
| 2022 Q2 | 1.93 Billion USD | 4.47% |
| 2022 FY | 7.85 Billion USD | 17.69% |
| 2022 Q4 | 2.01 Billion USD | -1.25% |
| 2022 Q1 | 1.85 Billion USD | 1.45% |
| 2022 Q3 | 2.04 Billion USD | 5.71% |
| 2021 Q3 | 1.74 Billion USD | 11.64% |
| 2021 FY | 6.67 Billion USD | 21.96% |
| 2021 Q1 | 1.53 Billion USD | 7.53% |
| 2021 Q4 | 1.82 Billion USD | 4.44% |
| 2021 Q2 | 1.56 Billion USD | 2.18% |
| 2020 Q2 | 1.33 Billion USD | -0.93% |
| 2020 Q1 | 1.35 Billion USD | 10.12% |
| 2020 FY | 5.46 Billion USD | 51.29% |
| 2020 Q3 | 1.35 Billion USD | 0.9% |
| 2020 Q4 | 1.42 Billion USD | 5.37% |
| 2019 FY | 3.61 Billion USD | 37.04% |
| 2019 Q3 | 817.91 Million USD | 1.53% |
| 2019 Q2 | 805.55 Million USD | 5.53% |
| 2019 Q4 | 1.22 Billion USD | 50.17% |
| 2019 Q1 | 763.34 Million USD | 2.08% |
| 2018 Q1 | 569.18 Million USD | 0.28% |
| 2018 Q2 | 647.77 Million USD | 13.81% |
| 2018 Q3 | 673.28 Million USD | 3.94% |
| 2018 FY | 2.63 Billion USD | 19.18% |
| 2018 Q4 | 747.81 Million USD | 11.07% |
| 2017 Q4 | 567.58 Million USD | 12.33% |
| 2017 Q1 | 667.73 Million USD | 67.68% |
| 2017 Q2 | 472.93 Million USD | -29.17% |
| 2017 FY | 2.21 Billion USD | 48.39% |
| 2017 Q3 | 505.29 Million USD | 6.84% |
| 2016 Q2 | 386.35 Million USD | 11.2% |
| 2016 FY | 1.49 Billion USD | 64.5% |
| 2016 Q4 | 398.22 Million USD | 10.71% |
| 2016 Q3 | 359.7 Million USD | -6.9% |
| 2016 Q1 | 347.43 Million USD | -1.72% |
| 2015 Q2 | 149.21 Million USD | 18.24% |
| 2015 Q4 | 353.52 Million USD | 27.23% |
| 2015 FY | 906.79 Million USD | 74.58% |
| 2015 Q3 | 277.85 Million USD | 86.21% |
| 2015 Q1 | 126.2 Million USD | -3.31% |
| 2014 Q4 | 130.52 Million USD | -20.8% |
| 2014 FY | 519.42 Million USD | -51.98% |
| 2014 Q2 | 121.12 Million USD | 17.62% |
| 2014 Q1 | 102.97 Million USD | -68.69% |
| 2014 Q3 | 164.8 Million USD | 36.06% |
| 2013 Q1 | 285.62 Million USD | 15.98% |
| 2013 FY | 1.08 Billion USD | -13.27% |
| 2013 Q4 | 328.89 Million USD | 69.22% |
| 2013 Q2 | 272.81 Million USD | -4.48% |
| 2013 Q3 | 194.36 Million USD | -28.76% |
| 2012 Q1 | 399.52 Million USD | -25.07% |
| 2012 Q2 | 303.88 Million USD | -23.94% |
| 2012 FY | 1.24 Billion USD | -6.24% |
| 2012 Q3 | 297.47 Million USD | -2.11% |
| 2012 Q4 | 246.27 Million USD | -17.21% |
| 2011 Q2 | 105.11 Million USD | 48.06% |
| 2011 Q3 | 620.79 Million USD | 490.57% |
| 2011 Q4 | 533.21 Million USD | -14.11% |
| 2011 FY | 1.33 Billion USD | 918.16% |
| 2011 Q1 | 70.99 Million USD | 13.64% |
| 2010 Q2 | 28.53 Million USD | 49.7% |
| 2010 Q3 | 20.56 Million USD | -27.93% |
| 2010 FY | 130.64 Million USD | 48.71% |
| 2010 Q4 | 62.47 Million USD | 203.76% |
| 2010 Q1 | 19.06 Million USD | -36.97% |
| 2009 Q1 | 20.4 Million USD | -28.65% |
| 2009 Q3 | 21.24 Million USD | 34.49% |
| 2009 Q2 | 15.79 Million USD | -22.58% |
| 2009 FY | 87.84 Million USD | -45.03% |
| 2009 Q4 | 30.24 Million USD | 42.35% |
| 2008 FY | 159.81 Million USD | -13.66% |
| 2008 Q4 | 28.59 Million USD | 4.31% |
| 2008 Q3 | 27.41 Million USD | -58.28% |
| 2008 Q2 | 65.7 Million USD | 72.47% |
| 2008 Q1 | 38.09 Million USD | -19.49% |
| 2007 FY | 185.1 Million USD | -9.34% |
| 2007 Q2 | 34.79 Million USD | -46.91% |
| 2007 Q4 | 47.32 Million USD | 26.35% |
| 2007 Q3 | 37.45 Million USD | 7.64% |
| 2007 Q1 | 65.54 Million USD | -28.04% |
| 2006 FY | 204.18 Million USD | 35.41% |
| 2006 Q1 | 36.09 Million USD | -40.81% |
| 2006 Q4 | 91.07 Million USD | 81.52% |
| 2006 Q3 | 50.17 Million USD | 86.94% |
| 2006 Q2 | 26.84 Million USD | -25.63% |
| 2005 FY | 150.79 Million USD | 55.35% |
| 2005 Q4 | 60.97 Million USD | 82.49% |
| 2005 Q3 | 33.41 Million USD | 12.0% |
| 2005 Q2 | 29.83 Million USD | 12.25% |
| 2005 Q1 | 26.57 Million USD | -29.74% |
| 2004 FY | 97.06 Million USD | 47.04% |
| 2004 Q3 | 25.36 Million USD | 47.34% |
| 2004 Q1 | 16.66 Million USD | 12.36% |
| 2004 Q4 | 37.82 Million USD | 49.14% |
| 2004 Q2 | 17.21 Million USD | 3.28% |
| 2003 Q3 | 16.7 Million USD | 4.13% |
| 2003 Q2 | 16.03 Million USD | -16.01% |
| 2003 Q4 | 14.83 Million USD | -11.18% |
| 2003 FY | 66.01 Million USD | -50.29% |
| 2003 Q1 | 19.09 Million USD | -48.65% |
| 2002 Q1 | 32.05 Million USD | -23.42% |
| 2002 Q2 | 35.86 Million USD | 11.9% |
| 2002 FY | 132.8 Million USD | 3.87% |
| 2002 Q3 | 27.69 Million USD | -22.78% |
| 2002 Q4 | 37.18 Million USD | 34.24% |
| 2001 Q2 | 20.52 Million USD | 12.63% |
| 2001 Q1 | 18.22 Million USD | 47.63% |
| 2001 FY | 127.86 Million USD | 72.68% |
| 2001 Q4 | 41.85 Million USD | 40.9% |
| 2001 Q3 | 29.7 Million USD | 44.75% |
| 2000 Q1 | 8.62 Million USD | -71.81% |
| 2000 FY | 74.04 Million USD | 13.92% |
| 2000 Q4 | 12.34 Million USD | -17.9% |
| 2000 Q3 | 15.03 Million USD | -60.49% |
| 2000 Q2 | 38.04 Million USD | 341.04% |
| 1999 Q2 | 15.5 Million USD | 198.08% |
| 1999 Q3 | 10.6 Million USD | -31.61% |
| 1999 Q4 | 30.6 Million USD | 188.68% |
| 1999 FY | 65 Million USD | 32.92% |
| 1999 Q1 | 5.2 Million USD | -60.31% |
| 1998 Q2 | 8.3 Million USD | 102.44% |
| 1998 FY | 48.9 Million USD | 3.16% |
| 1998 Q1 | 4.1 Million USD | -66.39% |
| 1998 Q3 | 19.5 Million USD | 134.94% |
| 1998 Q4 | 13.1 Million USD | -32.82% |
| 1997 Q1 | 7.7 Million USD | 40.0% |
| 1997 Q2 | 13 Million USD | 68.83% |
| 1997 FY | 47.4 Million USD | 187.27% |
| 1997 Q4 | 12.2 Million USD | -15.86% |
| 1997 Q3 | 14.5 Million USD | 11.54% |
| 1996 FY | 16.5 Million USD | -36.05% |
| 1996 Q3 | 3.7 Million USD | -7.5% |
| 1996 Q2 | 4 Million USD | 21.21% |
| 1996 Q4 | 5.5 Million USD | 48.65% |
| 1996 Q1 | 3.3 Million USD | -64.13% |
| 1995 Q1 | 6.1 Million USD | 64.86% |
| 1995 Q4 | 9.2 Million USD | 178.79% |
| 1995 Q3 | 3.3 Million USD | -54.17% |
| 1995 Q2 | 7.2 Million USD | 18.03% |
| 1995 FY | 25.8 Million USD | 11.69% |
| 1994 Q3 | 7.3 Million USD | 28.07% |
| 1994 FY | 23.1 Million USD | -27.36% |
| 1994 Q1 | 6.5 Million USD | -65.97% |
| 1994 Q2 | 5.7 Million USD | -12.31% |
| 1994 Q4 | 3.7 Million USD | -49.32% |
| 1993 Q4 | 19.1 Million USD | 260.38% |
| 1993 FY | 31.8 Million USD | 381.82% |
| 1993 Q1 | 1.7 Million USD | 0.0% |
| 1993 Q2 | 5.5 Million USD | 223.53% |
| 1993 Q3 | 5.3 Million USD | -3.64% |
| 1992 Q4 | 1.7 Million USD | 0.0% |
| 1992 Q2 | -1 Million USD | -166.67% |
| 1992 FY | 6.6 Million USD | 32.0% |
| 1992 Q1 | 1.5 Million USD | 15.38% |
| 1992 Q3 | 1.7 Million USD | 270.0% |
| 1991 FY | 5 Million USD | 117.39% |
| 1991 Q1 | 800 Thousand USD | 33.33% |
| 1991 Q3 | 1.2 Million USD | -7.69% |
| 1991 Q2 | 1.3 Million USD | 62.5% |
| 1991 Q4 | 1.3 Million USD | 8.33% |
| 1990 Q3 | 600 Thousand USD | 0.0% |
| 1990 Q1 | 500 Thousand USD | 0.0% |
| 1990 FY | 2.3 Million USD | 0.0% |
| 1990 Q4 | 600 Thousand USD | 0.0% |
| 1990 Q2 | 600 Thousand USD | 20.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -22535.108% |
| Alkermes plc | 1.37 Billion USD | -526.11% |
| Agenus Inc. | 139.61 Million USD | -6064.81% |
| Aptorum Group Limited | -1.11 Million USD | 772244.313% |
| Ardelyx, Inc. | 106.66 Million USD | -7969.491% |
| Dyadic International, Inc. | 922.95 Thousand USD | -932446.153% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -40767.005% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 4922802.081% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 64534.032% |
| Novavax, Inc. | 639.93 Million USD | -1244.976% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 18475.713% |
| Pyxis Oncology, Inc. | -2 Million USD | 430450.0% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 1665715.215% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -45097.71% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 19478238.861% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 1633306.831% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 8863.249% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -1073092.02% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 10496441.463% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -6262.877% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -109250.781% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 8977.772% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -467.039% |
| AlloVir, Inc. | -398 Thousand USD | 2162662.814% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -3475.301% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -2029852.83% |
| Bicycle Therapeutics plc | -129.52 Million USD | 6745.306% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -7172400.0% |
| ChromaDex Corporation | 50.78 Million USD | -16849.586% |
| Chimerix, Inc. | 324 Thousand USD | -2656381.481% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 27715.163% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 11191.781% |
| CRISPR Therapeutics AG | 240.95 Million USD | -3472.021% |
| Precision BioSciences, Inc. | 40.47 Million USD | -21166.555% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 8868.069% |
| Fortress Biotech, Inc. | 57.85 Million USD | -14777.362% |
| Fortress Biotech, Inc. | 57.85 Million USD | -14777.362% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -51821.337% |
| ImmuCell Corporation | 4.39 Million USD | -195678.981% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 8210.4% |
| Immix Biopharma, Inc. | -5468.00 USD | 157406830.066% |
| Incyte Corporation | 3.44 Billion USD | -150.156% |
| Innoviva, Inc. | 261.06 Million USD | -3196.88% |
| IO Biotech, Inc. | -756 Thousand USD | 1138592.063% |
| Jaguar Health, Inc. | 7.72 Million USD | -111331.901% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 1296334.94% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -7087.294% |
| ContextLogic Inc. | 59 Million USD | -14488.136% |
| MiMedx Group, Inc. | 266.84 Million USD | -3125.492% |
| MEI Pharma, Inc. | 49.32 Million USD | -17348.862% |
| NextCure, Inc. | -3.68 Million USD | 233731.922% |
| Onconetix, Inc. | -1.12 Million USD | 763697.166% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 29812.096% |
| Opthea Limited | 21.72 Thousand USD | -39626971.823% |
| Psyence Biomedical Ltd. | -240.00 USD | 3586250100.0% |
| Vaxcyte, Inc. | -75 Million USD | 11576.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 15014229.714% |
| Precigen, Inc. | 106 Thousand USD | -8119711.321% |
| Pharming Group N.V. | 220.1 Million USD | -3810.424% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -1671162.136% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -852922.795% |
| PureTech Health plc | -1.6 Million USD | 537030.755% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -7740.797% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 4844.554% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 19089.52% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 39245.859% |
| Acelyrin, Inc. | -115 Thousand USD | 7484447.826% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 85633370.321% |
| Summit Therapeutics Inc. | -2.05 Million USD | 419953.659% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 1507455.517% |
| Senti Biosciences, Inc. | -2.68 Million USD | 320897.615% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -212366.058% |
| Elevation Oncology, Inc. | -39 Thousand USD | 22069330.769% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 179487.245% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 218438.285% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -29447.873% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -1735182.258% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 15649190.909% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -8168.091% |
| Seer, Inc. | 7.02 Million USD | -122384.702% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -196496.619% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -39848.944% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 7263942.824% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 6006338.617% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -1413200.493% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -7044.28% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -2643.949% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 172140100.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -334282.284% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 16963048.364% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -29188.461% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 3710013.793% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 1749490.244% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 121359.51% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 1813837.369% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 82759715.385% |
| Soligenix, Inc. | 97.31 Thousand USD | -8844737.685% |
| Century Therapeutics, Inc. | -10.8 Million USD | 79728.088% |
| Kura Oncology, Inc. | -849 Thousand USD | 1013880.919% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 12926.359% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 5855202.041% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -8590.516% |
| Autolus Therapeutics plc | -4.86 Million USD | 176944.052% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -20696.888% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 5123314.286% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -8986.494% |
| GRI Bio, Inc. | 10.84 Million USD | -79293.045% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -338760.135% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 99179.084% |
| IGM Biosciences, Inc. | -211.66 Million USD | 4166.427% |
| INmune Bio, Inc. | 155 Thousand USD | -5552803.226% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -13795.93% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 571503.534% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 1327410.804% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 29401616.704% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -2140944.776% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 431312.425% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 2749940.256% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -9011.697% |
| Verastem, Inc. | -62 Thousand USD | 13882358.065% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -353370.226% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 3297801.149% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -284240.932% |
| Histogen Inc. | 3.76 Million USD | -228262.961% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -1493706.612% |
| Surrozen, Inc. | -27.23 Million USD | 31708.52% |
| Organovo Holdings, Inc. | -5.38 Million USD | 159814.233% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 714444.997% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 33659.481% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -42823.399% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 434697069.697% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -141779.325% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 12821300.34% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -5460.401% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -5903192.181% |
| Apollomics, Inc. | 127 Thousand USD | -6777065.354% |
| Amarin Corporation plc | 165.54 Million USD | -5099.316% |
| Mesoblast Limited | -9.81 Million USD | 87792.308% |
| Turnstone Biologics Corp. | 16.5 Million USD | -52044.675% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 7889.916% |
| Synaptogenix, Inc. | -6347.00 USD | 135607473.562% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 16876570.588% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -5233.87% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -389.685% |
| Better Therapeutics, Inc. | -2.72 Million USD | 315490.253% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 7773.79% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -2445.84% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 75447154.698% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 137592.013% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 776905.054% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -117514.086% |
| Insmed Incorporated | 239.63 Million USD | -3491.712% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -240453.382% |
| OmniAb, Inc. | 14.66 Million USD | -58582.757% |
| Alector, Inc. | -95.05 Million USD | 9154.948% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -6751.561% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 19903.051% |
| Zai Lab Limited | 170.9 Million USD | -4936.19% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -10412.11% |
| Aura Biosciences, Inc. | -1.29 Million USD | 664733.205% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -6620669.231% |
| Immunic, Inc. | -111 Thousand USD | 7754154.054% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -54189.138% |
| Veracyte, Inc. | 248.14 Million USD | -3368.495% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 223.15% |
| FibroGen, Inc. | 128.9 Million USD | -6577.062% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 1526063929.787% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 73872.905% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | -153.249% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -2212496.401% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -2322.153% |
| TG Therapeutics, Inc. | 219.1 Million USD | -3828.2% |
| Galecto, Inc. | -830 Thousand USD | 1037087.952% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 621544.043% |
| Fortrea Holdings Inc. | 424 Million USD | -1929.953% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 10088.743% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 1518089.418% |
| XBiotech Inc. | -1.74 Million USD | 493620.642% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 776905.054% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 18621.228% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 11494.869% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -11625.679% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -51122.996% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -2112.369% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 17436.395% |
| Vaxxinity, Inc. | -2.23 Million USD | 385373.053% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -2534.116% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 76107.772% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -35101.014% |
| NexImmune, Inc. | -1.02 Million USD | 839830.256% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -159388788.889% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 121228.858% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 23.841% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 12879624.743% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 242482.427% |
| Ainos, Inc. | -253.73 Thousand USD | 3392248.44% |
| Pluri Inc. | 322 Thousand USD | -2672881.366% |
| Prothena Corporation plc | -129.2 Million USD | 6761.713% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -16969.273% |
| Celularity Inc. | 6.75 Million USD | -127316.728% |
| Rallybio Corporation | -150 Thousand USD | 5738100.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 26496.173% |
| MeiraGTx Holdings plc | 287 Thousand USD | -2998854.704% |
| Omeros Corporation | -69.77 Million USD | 12434.657% |
| Humacyte, Inc. | -76.55 Million USD | 11343.632% |
| Immunocore Holdings plc | 248.39 Million USD | -3365.101% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 56840.721% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -13697.249% |
| Blueprint Medicines Corporation | 236.58 Million USD | -3538.031% |
| CalciMedica, Inc. | -58 Thousand USD | 14839755.172% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 603676.438% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -29523.129% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 302737.131% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 27985.955% |
| Pulmatrix, Inc. | -8.22 Million USD | 104808.029% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 735741.026% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 2157242.857% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 2258.257% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -309996.79% |
| Cytokinetics, Incorporated | -322.59 Million USD | 2768.068% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -998270.268% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 2524146.921% |
| Vor Biopharma Inc. | -3.49 Million USD | 246577.663% |
| Roivant Sciences Ltd. | 109.23 Million USD | -7779.343% |
| Evogene Ltd. | 1.39 Million USD | -615125.161% |
| ProKidney Corp. | -3.16 Million USD | 271699.874% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 19700.565% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -125421.365% |
| CorMedix Inc. | -205.56 Thousand USD | 4187157.919% |
| BioLineRx Ltd. | 1.1 Million USD | -776705.054% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 11040.499% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 26081918.182% |
| Atai Life Sciences N.V. | -5000.00 USD | 172140100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 7063181.102% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 8965725.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 619754.428% |
| Sagimet Biosciences Inc. | 2 Million USD | -430250.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -878429.762% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 10307.664% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 9102738.676% |
| GeoVax Labs, Inc. | -20.72 Million USD | 41638.04% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -3419.742% |
| Biomea Fusion, Inc. | -4.2 Million USD | 204979.791% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -886.661% |
| Mereo BioPharma Group plc | 7.42 Million USD | -115803.582% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 2776551.613% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 71725100.0% |
| Absci Corporation | -41.84 Million USD | 20666.8% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 172140100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 11369.69% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 349835.88% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -3926.949% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 914765.25% |
| Allakos Inc. | -6.14 Million USD | 140256.326% |
| Imunon, Inc. | -720 Thousand USD | 1195508.365% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 12574.636% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -1708.596% |
| BioAtla, Inc. | -103.73 Million USD | 8397.423% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 75447154.698% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 4835493.258% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 3644.616% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 2767624.116% |
| XOMA Corporation | 3.86 Million USD | -222821.523% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 12380.802% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -58078.991% |
| aTyr Pharma, Inc. | -2.38 Million USD | 360527.136% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -68977.047% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 29679410.345% |
| Viridian Therapeutics, Inc. | -1 Million USD | 853969.048% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -66207692207.692% |
| Akari Therapeutics, Plc | -4000.00 USD | 215175100.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -1251.407% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -4420365.518% |
| UroGen Pharma Ltd. | 73.35 Million USD | -11633.831% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 32343.201% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -74134266.925% |
| Orgenesis Inc. | -5.72 Million USD | 150440.611% |
| Entera Bio Ltd. | -56 Thousand USD | 15369742.857% |
| GH Research PLC | -315 Thousand USD | 2732480.952% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 4554068.254% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 1639528.571% |
| Xencor, Inc. | -85.26 Million USD | 10195.004% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 3895075.495% |
| Replimune Group, Inc. | -2.65 Million USD | 324280.791% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 859737.488% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -4739.635% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -4420365.518% |
| Portage Biotech Inc. | -54 Thousand USD | 15938988.889% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 9102738.676% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 2283123.873% |
| OncoCyte Corporation | 413 Thousand USD | -2083919.37% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 191479521.58% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 3877027127.027% |
| Purple Biotech Ltd. | -196 Thousand USD | 4391426.531% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -95874.576% |
| scPharmaceuticals Inc. | 9.78 Million USD | -87888.141% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 82503.403% |
| HilleVax, Inc. | -2.15 Million USD | 399311.503% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 8873295.876% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 57364802.746% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 1288573.054% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 37421839.13% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 114665921.139% |
| Savara Inc. | -44.26 Million USD | 19545.574% |
| Curis, Inc. | 9.81 Million USD | -87628.06% |
| Daré Bioscience, Inc. | 2.76 Million USD | -310675.65% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 6897397.817% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 497902.198% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 3775100.0% |
| BeiGene, Ltd. | 2.07 Billion USD | -314.025% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 307943.628% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 2253.559% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -15083.108% |
| Erasca, Inc. | -3.73 Million USD | 230727.01% |
| bluebird bio, Inc. | -4.03 Million USD | 213673.201% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 30501907.357% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -351.96% |
| DBV Technologies S.A. | 15.72 Million USD | -54624.059% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 30501907.357% |
| Moderna, Inc. | 2.15 Billion USD | -299.397% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 940755.738% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -107406.87% |
| Molecular Templates, Inc. | 50.39 Million USD | -16979.075% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 1605883.582% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -6333.312% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 138431.726% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 21976.827% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 7845.123% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 239982.943% |
| MacroGenics, Inc. | 50.52 Million USD | -16934.457% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 141244.638% |
| Prime Medicine, Inc. | -147.9 Million USD | 5919.276% |
| Aditxt, Inc. | -111.66 Thousand USD | 7708321.386% |
| Adagene Inc. | 18.11 Million USD | -47422.316% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -1763629.508% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -6038.999% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -5353.129% |
| SciSparc Ltd. | 2.19 Million USD | -391839.891% |
| Vericel Corporation | 135.57 Million USD | -6248.469% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 34360753.12% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 27780746.827% |
| Generation Bio Co. | -73.91 Million USD | 11745.087% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 1969665.217% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -15658.253% |
| Invivyd, Inc. | -2.02 Million USD | 424508.284% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 2960.98% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 8321026.545% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -8831.388% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -8656.918% |
| ADMA Biologics, Inc. | 88.21 Million USD | -9656.512% |
| Clene Inc. | 533 Thousand USD | -1614721.764% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -35600.088% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 899473.041% |
| GeoVax Labs, Inc. | -20.72 Million USD | 41638.04% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -432847.686% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 4429483.067% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -17181.397% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 121462.098% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 1029645.455% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -10218.288% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -11772249.272% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -16090.136% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 5069.744% |
| Trevena, Inc. | 1.45 Million USD | -591446.392% |
| Surrozen, Inc. | -27.23 Million USD | 31708.52% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 2438343.626% |
| Cingulate Inc. | -582.91 Thousand USD | 1476637.009% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 27764616.129% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 43792.573% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 113698911.096% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 977058.002% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -1164.423% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 871253.846% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 15276448.017% |
| Kronos Bio, Inc. | 1.37 Million USD | -627232.362% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 16138.087% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 2947702.74% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 1762695.379% |
| ImmunityBio, Inc. | -17.89 Million USD | 48210.676% |
| Korro Bio, Inc. | -3.63 Million USD | 237207.438% |
| Kineta, Inc. | 5.43 Million USD | -158320.762% |
| BioVie Inc. | -229.37 Thousand USD | 3752437.854% |
| Codexis, Inc. | 57.33 Million USD | -14912.035% |
| Celularity Inc. | 6.75 Million USD | -127316.728% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -214377.947% |
| Celcuity Inc. | -142.77 Thousand USD | 6028592.982% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -17013143.724% |
| Cibus, Inc. | 1.42 Million USD | -605174.262% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 2301436.898% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 37653.995% |
| IN8bio, Inc. | -2.5 Million USD | 344242.343% |
| Kodiak Sciences Inc. | -25.94 Million USD | 33271.465% |
| Annexon, Inc. | -3.26 Million USD | 263552.709% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 421186.106% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 20721.99% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -1344743.75% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -1005.568% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -4876.439% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 453100.0% |
| Arcellx, Inc. | 108.27 Million USD | -7848.91% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 26690.256% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -10766.875% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 40791.188% |
| Moolec Science SA | -143.3 Thousand USD | 6006170.968% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 20438.863% |
| Geron Corporation | -123.5 Million USD | 7069.061% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -261749.711% |
| Royalty Pharma plc | 1.79 Billion USD | -379.793% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 12379.926% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 238289136.545% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -3719577.948% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 7825.241% |
| Humacyte, Inc. | -76.55 Million USD | 11343.632% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 906888.429% |
| 89bio, Inc. | -273 Thousand USD | 3152847.253% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 684825.537% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 1015076.415% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 6997660.976% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -769068.901% |
| Notable Labs, Ltd. | 113 Thousand USD | -7616714.159% |
| Liquidia Corporation | 14.6 Million USD | -58852.055% |
| Mustang Bio, Inc. | -2.22 Million USD | 386931.461% |
| Immunovant, Inc. | -231 Thousand USD | 3726074.026% |
| Quantum-Si incorporated | 488 Thousand USD | -1763629.508% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 15591.64% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 28690100.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -462144.898% |
| Acasti Pharma Inc. | -11 Thousand USD | 78245554.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 4206495.363% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 1327410.804% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 5238.139% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -758506.709% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 2259155.118% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 439681.205% |
| PepGen Inc. | -1.18 Million USD | 727042.568% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 6777265.354% |
| United Therapeutics Corporation | 2.07 Billion USD | -315.797% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 37690.077% |
| Solid Biosciences Inc. | -76.56 Million USD | 11341.723% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 10422341.866% |
| Immuneering Corporation | -764.13 Thousand USD | 1126467.227% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -12988853.278% |
| Belite Bio, Inc | -399 Thousand USD | 2157242.857% |
| XOMA Corporation | 3.86 Million USD | -222821.523% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 43057.676% |
| Bionomics Limited | -434.44 Thousand USD | 1981230.121% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 801496.648% |
| uniQure N.V. | 2.21 Million USD | -388477.878% |
| Cassava Sciences, Inc. | -89.42 Million USD | 9725.041% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 9448.423% |
| Forte Biosciences, Inc. | -9000.00 USD | 95633433.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 1030878.443% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 1969665.217% |
| Altimmune, Inc. | -65.37 Million USD | 13265.986% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -2277.427% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 801496.648% |
| Compugen Ltd. | 31.45 Million USD | -27262.899% |
| Peak Bio, Inc. | 367.76 Thousand USD | -2340227.76% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -35007.685% |
| Benitec Biopharma Inc. | 108 Thousand USD | -7969344.444% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 11034715.385% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 715561.347% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 472492.975% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 7232873.109% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 715561.347% |
| Instil Bio, Inc. | -4.75 Million USD | 181071.405% |
| argenx SE | 1.1 Billion USD | -676.468% |
| Immunome, Inc. | -8.9 Million USD | 96731.863% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 455496.825% |
| Verona Pharma plc | -679.62 Thousand USD | 1266535.558% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 4918385.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 360980.503% |
| CervoMed Inc. | -1.29 Million USD | 665438.618% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 357682.052% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 180275.843% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -348220.518% |
| Moolec Science SA | -143.3 Thousand USD | 6006170.968% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 2109503.72% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 322275.175% |
| AnaptysBio, Inc. | 14.78 Million USD | -58130.16% |
| Design Therapeutics, Inc. | -537 Thousand USD | 1602893.296% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 2015790.867% |
| NeurAxis, Inc. | 2.15 Million USD | -398981.191% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -400971.761% |
| Lumos Pharma, Inc. | 2 Million USD | -428749.028% |
| Achilles Therapeutics plc | -4.73 Million USD | 182017.444% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 4918385.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 8144883.534% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -27086.794% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -998270.268% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 834111.628% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 18996.549% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -20016179.07% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 1047180.292% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 65412776.699% |
| Palisade Bio, Inc. | 246 Thousand USD | -3498680.488% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 26081918.182% |
| Beam Therapeutics Inc. | -59.67 Million USD | 14523.85% |
| Neurogene Inc. | -3.26 Million USD | 263956.53% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -6077.199% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 233225.677% |
| Sesen Bio, Inc. | 40 Million USD | -21417.5% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 2898079.798% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 213830.343% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 90074.911% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -61029.261% |
| Athira Pharma, Inc. | -969 Thousand USD | 888335.294% |
| Vaccinex, Inc. | -16 Million USD | 53880.305% |
| HCW Biologics Inc. | -574.82 Thousand USD | 1497427.878% |
| XOMA Corporation | 3.86 Million USD | -222821.523% |
| Nektar Therapeutics | 53.47 Million USD | -15994.469% |
| Arvinas, Inc. | 71.8 Million USD | -11887.465% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 10412.599% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 13810.872% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 2673081.366% |
| Rezolute, Inc. | -36 Thousand USD | 23908433.333% |
| Clene Inc. | 533 Thousand USD | -1614721.764% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 670327202.804% |
| BeyondSpring Inc. | 1.75 Million USD | -491447.687% |
| Synlogic, Inc. | -1.92 Million USD | 447449.272% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 23262262.162% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 136028.617% |
| Peak Bio, Inc. | 367.76 Thousand USD | -2340227.76% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 45488.388% |
| Krystal Biotech, Inc. | 47.6 Million USD | -17980.034% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -6000.318% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -171183.582% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 332516.841% |
| MannKind Corporation | 136.19 Million USD | -6219.801% |
| Ikena Oncology, Inc. | -50.49 Million USD | 17146.265% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -7809.828% |
| Gossamer Bio, Inc. | -4.38 Million USD | 196382.782% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 3415576.19% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 172140100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -6007.331% |
| Mural Oncology plc | -2.56 Million USD | 335394.118% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 1562168.966% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 8607100.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -41371.524% |
| REGENXBIO Inc. | 53.02 Million USD | -16130.742% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 160769.694% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 4474174.074% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 497039.954% |
| Vaxart, Inc. | -60.76 Million USD | 14264.87% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 3275463.422% |
| Cellectis S.A. | 18 Thousand USD | -47816566.667% |
| Longeveron Inc. | 221 Thousand USD | -3894470.136% |
| Repare Therapeutics Inc. | -80.07 Million USD | 10849.344% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -687.471% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 665246.832% |
| Revolution Medicines, Inc. | -399.66 Million USD | 2253.559% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 24591528.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -17565206.122% |
| Denali Therapeutics Inc. | -93.34 Million USD | 9320.633% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 34360753.12% |
| Veru Inc. | 7.56 Million USD | -113660.004% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 5700100.0% |
| Cingulate Inc. | -582.91 Thousand USD | 1476637.009% |
| Passage Bio, Inc. | -3.72 Million USD | 231408.788% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 71463069.113% |
| Exicure, Inc. | -1.42 Million USD | 604948.911% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 2247358.486% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -318323.973% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 1678941.371% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -12533.943% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 5753173.051% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 14637.378% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -2201178.772% |
| OmniAb, Inc. | 14.66 Million USD | -58582.757% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -42950.068% |
| Lipocine Inc. | -2.85 Million USD | 302013.346% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 467110.309% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 150967.66% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 571503.534% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -11327.851% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 13241638.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -10110.449% |
| Ocugen, Inc. | -33.53 Million USD | 25764.192% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 272301.139% |
| Q32 Bio Inc. | 578 Thousand USD | -1489000.346% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 3248024.528% |
| Alumis Inc. Common Stock | -1.28 Million USD | 670427.103% |
| Equillium, Inc. | 35.95 Million USD | -23836.259% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 504317.926% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -1718965.509% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 208200390.276% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 3323266.023% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -2036038.08% |
| Dominari Holdings Inc. | 2.03 Million USD | -422018.686% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 4691304.605% |
| vTv Therapeutics Inc. | -13.59 Million USD | 63410.04% |
| Bio-Techne Corporation | 773.07 Million USD | -1013.347% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -49596.865% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -1767.895% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 736370.317% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 35992.41% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -73482.97% |
| Nkarta, Inc. | -5.86 Million USD | 146751.9% |
| BioCardia, Inc. | -7.24 Million USD | 118833.618% |
| Iterum Therapeutics plc | -1.75 Million USD | 491928.571% |